Is this you? Create Your Porfile
Avatar

Jautelat Rolf

Schering AG

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Jautelat Rolf is active.

Explore More

Publication

Featured researches published by Jautelat Rolf.

Archive | 2003

17.ALPHA.-ALKYL-17.BETA.-OXY-ESTRATRIENES AND INTERMEDIATES FOR THE PRODUCTION THEREOF, AND USE OF SAID 17.ALPHA.-ALKYL-17.BETA.-OXY-ESTRATRIENES FOR PRODUCING MEDICAMENTS AND PHARMACEUTICAL PREPARATIONS

Bohlmann Rolf; Heinrich Nikolaus; Jautelat Rolf; Kroll Jorg; Petrov Orlin; Reichel Andreas; Hoffmann Jens; Lichtner Rosemarie

Archive | 2002

1-Indolylderivate, deren Verwendung zur Herstellung von Arzneimitteln, ein Verfahren zur Herstellung der 1-Indolylderivate sowie 1-Indolylderivate enthaltende pharmzeutische Präparate

Hoffmann Jens; Bohlmann Rolf; Jautelat Rolf; Heinrich Nicolaus; Lichtner Rosemarie; Angerer Erwin Von; Golob Thomas; Walter Georg

Archive | 2003

17alpha-Alkyl-17ß-oxy-estratriene und Zwischenprodukte zu deren Herstellung, Verwendung der 17alpha-Alkyl-17ß-oxy-estratriene zur Herstellung von Arzneimitteln sowie pharmazeutische Präparate

Bohlmann Rolf; Heinrich Nikolaus; Jautelat Rolf; Kroll Jorg; Petrov Orlin; Reichel Andreas; Hoffmann Jens; Lichtner Rosemarie

Archive | 2017

ΣΟΥΛΦΟΞΙΜΙΝΥΠΟΚΑΤΕΣΤΗΜΕΝΑ ΠΑΡΑΓΩΓΑ ΑΝΙΛΙΝΟΠΥΡΙΜΙΔΙΝΗΣ ΩΣ CDK-ΑΝΑΣΤΟΛΕΙΣ, Η ΠΑΡΑΓΩΓΗ ΑΥΤΩΝ ΚΑΙ Η ΧΡΗΣΗ ΑΥΤΩΝ ΩΣ ΦΑΡΜΑΚΕΥΤΙΚΑ ΜΕΣΑ

Lücking Ulrich; Jautelat Rolf; Siemeister Gerhard; Schulze Julia; Lienau Philip

Archive | 2016

Derivados de anilinopirimidina sustituidos con sulfona como inhibidores de CDK, su preparación y su uso como fármaco

Lücking Ulrich; Siemeister Gerhard; Lienau Philip; Jautelat Rolf; Schulze Julia

Archive | 2015

ΠΥΡΙΜΙΔΙΝΕΣ ΥΠΟΚΑΤΕΣΤΗΜΕΝΕΣ ΜΕ ΣΟΥΛΦΟΞΙΜΙΝΗ ΩΣ ΑΝΑΣΤΟΛΕΙΣ CDK ΚΑΙ/Ή VEGF, Η ΠΑΡΑΣΚΕΥΗ ΤΟΥΣ ΚΑΙ Η ΧΡΗΣΗ ΤΟΥΣ ΩΣ ΦΑΡΜΑΚΕΥΤΙΚΑ ΜΕΣΑ

Lücking Urlich; Kruger Martin; Jautelat Rolf; Siemeister Gerhard

Archive | 2015

Imidazopirazinas 6-tiosustituidas para uso como inhibidores de MPS-1 y TKK en el tratamiento de trastornos hiperproliferativos

Koppitz Marcus; Klar Ulrich; Jautelat Rolf; Kosemund Dirk; Bohlmann Rolf; Bader Benjamin; Lienau Philip; Siemeister Gerhard

Archive | 2015

derivados de anilinopirimidina substituídos com sulfoximina como inibidores cdk, sua produção e uso como medicamento.

Siemeister Gerhard; Schulze Julia; Lienau Philip; Jautelat Rolf; Lücking Ulrich

Archive | 2014

Derivados de anilino-pirimidina sustituidos con sulfoximina como inhibidores de CDK, su preparación y uso como medicamentos

Lücking Ulrich; Jautelat Rolf; Siemeister Gerhard; Schulze Julia; Lienau Philip

Archive | 2014

17α-ΑΛΚΥΛΟ-17β-ΟΞΥ-ΟΙΣΤΡΑΤΡΙΕΝΙΑ ΚΑΙ ΕΝΔΙΑΜΕΣΑ ΠΡΟΪΟΝΤΑ ΓΙΑ ΤΗΝ ΠΑΡΑΓΩΓΗ ΑΥΤΩΝ, Η ΧΡΗΣΗ ΤΩΝ 17α-ΑΛΚΥΛΟ-17β-ΟΞΥ-ΟΙΣΤΡΑΤΡΙΕΝΙΩΝ ΓΙΑ ΤΗΝ ΠΑΡΑΓΩΓΗ ΦΑΡΜΑΚΕΥΤΙΚΩΝ ΜΕΣΩΝ ΚΑΘΩΣ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΑ ΠΑΡΑΣΚΕΥΑΣΜΑΤΑ

Bohlmann Rolf; Heinrich Nikolaus; Jautelat Rolf; Kroll Jorg; Petrov Orlin; Reichel Andreas; Hoffmann Jens; Lichtner Rosemarie

Explore More

Collaboration

Dive into the Jautelat Rolf's collaboration.

Top Co-Authors
Avatar

Bohlmann Rolf

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Hoffmann Jens

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Lichtner Rosemarie

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Heinrich Nikolaus

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Kroll Jorg

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Petrov Orlin

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Reichel Andreas

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Siemeister Gerhard

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Lienau Philip

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Hegele-Hartung Christa

Schering AG

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge